Director, Heart Failure and Transplantation
Vanderbilt University
Nashville, Tennessee, United States
Dr. Lindenfeld is a Heart Failure/Transplant Cardiologist at Vanderbilt University Medical Center. She has over 30 years experience with clinical trials and has served on the FDA Cardiorenal and Devices Panel. She has written the HFSA heart failure guidlines and has been a member of the AHA/ACC/HFSA Guidelines. Her main area of research is the use of devices in heart failure.
Disclosure information not submitted.
What is the Future of Atrial Shunts and Where do we go From Here?
Sunday, March 8, 2026
10:18 AM - 10:26 AM EST
Panel Discussion | Devices in Heart Failure
Sunday, March 8, 2026
11:14 AM - 11:34 AM EST
VALVES AND INTRA-ATRIAL SHUNTS AND HEART FAILURE
Sunday, March 8, 2026
11:34 AM - 12:45 PM EST
What Should Be the Clinical Trial Design for the Next Atrial Shunt Device?
Sunday, March 8, 2026
12:14 PM - 12:22 PM EST
Panel Discussion | Valves, Intra-Atrial Shunts and Heart Failure
Sunday, March 8, 2026
12:30 PM - 12:45 PM EST